Aflibercept biosimilar (Coherus BioSciences)

阿柏西普生物类似药（Coherus BioSciences）

Report date: 2025/08/01 14:25:40

Base Information

Drug NameAflibercept biosimilar (Coherus BioSciences)
Drug Alias NameCHS-2020
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar
Mechanisms of ActionPlacental Growth Factor inhibitorsVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor APlacental Growth Factor
Therapy Area/IndicationsMacular Edema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCoherus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCoherus Biosciences Inc
Active IndicationsN/A
Inactive IndicationsMacular Edema

Other Information

ATC CodeN/A
Related LinksN/A